Glycorex Transplantation AB (publ)
Research Glycorex Transplantation AB (publ) (O33) on Bullrun: market cap EUR 11.04M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerO33
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 11.04M
- Financial periodFY2024
- RevenueSEK 35.16M
- Revenue growth17.3%
- Net income-SEK 10.94M
- Free cash flowSEK 101.00K
Valuation Snapshot
latest market cap is EUR 11.04M.
About Glycorex Transplantation AB (publ)
Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company's principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures.
Frequently asked questions
What is Glycorex Transplantation AB (publ)'s market cap?
Glycorex Transplantation AB (publ)'s market capitalization is EUR 11.04M.
What does Glycorex Transplantation AB (publ) do?
Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood.